<DOC>
	<DOCNO>NCT02375165</DOCNO>
	<brief_summary>Acquired lymphedema disease cause chronic swell limb ( ) . It frequently under-recognized misdiagnosed . This study design lead development accurate , noninvasive , blood test allow test lymphedema .</brief_summary>
	<brief_title>Biomarkers Detection Lymphatic Insufficiency</brief_title>
	<detailed_description>The validation sensitive specific biomarker assay human acquire lymphatic vascular insufficiency would represent highly significant development patient community . Accurate bioassay presence lymphatic vascular insufficiency help pave road future human clinical trial experimental drug therapy design treat human lymphatic disease . Molecular profiling perform human tissue ( skin ) obtain biopsy . The insight gain initial analysis determine target assay human body fluid ( blood ) .</detailed_description>
	<mesh_term>Lymphedema</mesh_term>
	<criteria>For lymphedema participant : history acquire lymphedema least 6 month ' duration . For nonlymphedema participant risk factor : undergone lymph node dissection and/or radiation therapy evidence lymphedema Control participant : evidence lymphedema , lymph node dissection , radiation therapy active cancer , infection bleeding tendency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>